Business · 1 sources covering this

Aurobindo Pharma's Q1 Margin Story Improves; Macquarie Says Growth Picture Is Still Uneven

Aurobindo Pharma reported a 25.2% year-on-year (YoY) rise in consolidated net profit to Rs 1,033 crore, while revenue increased 16.3% to Rs 9,150 crore.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

NDTVCenter·2h ago
Aurobindo Pharma's Q1 Margin Story Improves; Macquarie Says Growth Picture Is Still Uneven
Aurobindo Pharma reported a 25.2% year-on-year (YoY) rise in consolidated net profit to Rs 1,033 crore, while revenue increased 16.3% to Rs 9,150 crore.
Read at NDTV →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/f33c1a0a9476c5dbb3a6c27b8940b931e1837bbd"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Aurobindo Pharma's Q1 Margin Story Improves; Macquarie Says Growth Picture Is Still Uneven"></iframe>

Aurobindo Pharma's Q1 Margin Story Improves; Macquarie Says Growth Picture Is Still Uneven

How 1 sources are covering this

Aurobindo Pharma's Q1 Margin Story Improves; Macquarie Says Growth Picture Is Still Uneven

More from Business

Rupee falls 9 paise to 95.17 against U.S. dollar in early trade

MHADA lottery results 2026 today: When, where and how to check draw status for Mumbai's 2,640 budget homes

India, Sri Lanka to deepen FTA ties

Shiprocket's Rs 7K-cr IPO rewards early backers

Reader

Trust & legal

Across the network